Our results showed that the downregulation of Elovl5 expression inhibited the proliferation of breast cancer cells and reduced mammary tumor growth in murine models, which is consistent with a recent publication on prostate cancer [21]. This evidence concerns the gene ELOVL5 and prostate carcinoma.